Atypical Endometrial Hyperplasia and Well Differentiated Endometrioid Adenocarcinoma of the Uterine Corpus

Surgical Pathology Clinics
Anne M Mills, Teri A Longacre

Abstract

The distinction between atypical endometrial hyperplasia and well differentiated adenocarcinoma of the endometrium is one of the more difficult differential diagnoses in gynecologic pathology. Different pathologists apply different histologic criteria, often with different individual thresholds for atypical endometrial hyperplasia and grade 1 adenocarcinoma. While some classifications are based on a series of molecular genetic alterations (which may or may not translate into biologically or clinically relevant risk lesions), almost all current diagnostic criteria use a series of histologic features - usually a combination of architecture and cytology - for diagnosing atypical hyperplasia and adenocarcinoma. This article presents evidence-based histologic criteria for atypical endometrial hyperplasia and low grade endometrial carcinoma (both FIGO grade 1 and 2) with emphasis on common and not so common histologic mimics. Grade 3 endometrioid carcinoma is discussed in the Oliva and Soslow article in this publication.

References

Jan 1, 1989·American Journal of Obstetrics and Gynecology·A Ferenczy, M Gelfand
Jan 1, 1983·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·A Kumar, V Schneider
Jul 1, 1981·The American Journal of Surgical Pathology·M T Mazur
Jul 1, 1996·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R A SoslowT A Longacre
Apr 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·M R Emmert-BuckM J Merino
Aug 26, 1998·The American Journal of Surgical Pathology·B S KendallR J Kurman
Jul 1, 1999·Gynecologic Oncology·R R TaylorD M O'Connor
Jun 8, 2000·Journal of the National Cancer Institute·G L MutterC Eng
Dec 8, 2000·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·G L Mutter
Jan 10, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Diego H CastrillonMarisa R Nucci
Jan 10, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·W Glenn McCluggageAnna Patterson
Jun 18, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Xavier Matias-GuiuJaime Prat
Jun 18, 2002·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Seiryu KamoiSteven G Silverberg
Sep 23, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Shawn K MurrayRobert E Scully
Nov 15, 2003·International Journal of Surgical Pathology·Russell Vang, Fattaneh A Tavassoli
Oct 7, 2004·Journal of the National Cancer Institute·Dirk BrinkmannIan J Jacobs
Aug 25, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Julie A IrvingJaime Prat
Mar 17, 2007·Pathology·Jaime PratLluis Catasús
Jun 27, 2007·The American Journal of Surgical Pathology·Darren T WheelerRobert J Kurman
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimio UshijimaToshiharu Kamura
Feb 28, 2008·The American Journal of Surgical Pathology·Sanjay LoganiKaren A Moller
Sep 9, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·O GemerO Lavie
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Susan J RamusSimon A Gayther
Jan 20, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elke A JarboeChristopher P Crum
Dec 1, 2009·Surgical Pathology Clinics·Robert A Soslow

❮ Previous
Next ❯

Citations

Aug 21, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Taner TuranMehmet Faruk Kose

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.